KVUE — Kenvue Inc.

NYSE · Materials · Chemicals · CIK 1944048 ·
Last close
$18.41
Market Cap
$35.35B
52W High
$18.53
52W Low
$16.44
ADV30
20,906,592
Next earnings
2026-08-06
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 3,909,000,000 2,302,000,000 838,000,000 474,000,000 26,854,000,000 1,075,000,000 16,246,000,000
Dec 2025 3,780,000,000 2,137,000,000 632,000,000 330,000,000 27,076,000,000 1,062,000,000 16,311,000,000
Sep 2025 3,764,000,000 2,226,000,000 713,000,000 398,000,000 27,248,000,000 1,139,000,000 16,614,000,000
Jun 2025 3,839,000,000 2,261,000,000 752,000,000 420,000,000 27,132,000,000 1,070,000,000 16,402,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,258,000,000
Investing CF
$-436,000,000
Financing CF
$-1,822,000,000
CapEx
$-435,000,000
Dividends Paid
$-1,587,000,000
Buybacks
$-134,000,000
EPS Diluted TTM
$0.85
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-128,000,000
Inventory
$1,674,000,000
Receivables
$2,911,000,000
ST Investments
EBIT TTM
$2,642,000,000
Pretax Income TTM
$2,213,000,000
Interest Exp TTM
$429,000,000
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$15,292,000,256
EBITDA
$3,470,000,128
Free Cash Flow
$1,858,000,000
Enterprise Value
$43,074,359,296
Total Cash
$1,075,000,064
Total Debt
$8,801,999,872
Shares Out
1,920,008,668
Trailing EPS
$0.84
Book Value
$5.53
ROE
15.7%
ROA
7.1%
Div Yield
4.51%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 15,124,000,000 2,715,000,000 1,470,000,000 27,076,000,000 16,311,000,000 2,197,000,000
Dec 2024 15,455,000,000 2,629,000,000 1,030,000,000 25,601,000,000 15,933,000,000 1,769,000,000
Dec 2023 15,444,000,000 2,493,000,000 1,664,000,000 27,851,000,000 16,640,000,000 3,168,000,000
Dec 2022 14,950,000,000 2,688,000,000 2,064,000,000 27,316,000,000 7,346,000,000 2,525,000,000

TTM Snapshot

Revenues TTM
$11,603,000,000
NetIncome TTM
$1,407,000,000
OpCashFlow TTM
$0
Assets (Latest)
$25,601,000,000
Forward EPS
$1.24

Max Pain — expiry 2026-07-17

max pain strike: $18.00 · spot: $18.78 · call oi: 8,878 · put oi: 750
Expected Move to 2026-07-17: ±$0.83 (4.45%) — implied range $17.94$19.61 · ATM straddle on $19.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
HLNCF Haleon plc $38.00B $4.31
HLN Haleon plc $39.45B $8.95
NTR Nutrien Ltd. $29.54B $61.54
CTA-PA EIDP, Inc. $46.18B $53.22
PPG PPG INDUSTRIES INC $26.24B $117.70

News headlines (Yahoo Finance, 1h cache)

Piper Sandler Raises Kimberly-Clark (KMB) Price Target, Sees Long-Term Upside from Kenvue Deal
2026-06-19 03:28 · Yahoo
J&J Skips GLP-1 Race, Targets No. 1 Cancer Spot By 2030
2026-06-17 19:33 · Yahoo
1 Dividend King to Buy Hand Over Fist Right Now
2026-06-17 19:05 · Yahoo
Kenvue, Maker of Neutrogena(R), Aveeno(R), OGX(R), and Zyrtec(R), Beats 2025 Packaging Goal, Demonstrates Continued Progress With More Sustainable Innovation
2026-06-16 14:30 · Yahoo
Mondelēz International Names Amit Banati Executive Vice President and Chief Financial Officer
2026-06-15 20:45 · Yahoo
Jim Cramer Says He Likes Drug Stocks Here As He Discusses Johnson & Johnson
2026-06-12 14:45 · Yahoo
Is Kenvue Stock Underperforming the S&P 500?
2026-06-10 10:40 · Yahoo
Women Leaders Take Centre Stage at Procurement LIVE: The London Summit This September
2026-06-08 08:00 · Yahoo
Does Kenvue (KVUE) Offer Value After Share Price Decline And DCF Upside Projection
2026-06-06 08:07 · Yahoo
Jim Cramer Says He Likes “Kimberly-Clark Because It’s Merging With Kenvue”
2026-06-05 14:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.